The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene

[1]  Guangying Zhang,et al.  Utility of Serum EB Virus Zta Antibody in the Diagnostic of Nasopharyngeal Carcinoma: Evidences From 2,126 Cases and 15,644 Controls , 2019, Front. Oncol..

[2]  A. Adamson,et al.  BZLF1 transcript variants in Epstein–Barr virus-positive epithelial cell lines , 2019, Virus Genes.

[3]  Y. Kook,et al.  Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine , 2018, Front. Immunol..

[4]  Xiuzhen Li,et al.  Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes. , 2017, Vaccine.

[5]  S. Tonegawa,et al.  Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma , 2010, Protein & Cell.

[6]  T. Griffith,et al.  The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette–Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder , 2009, Cancer and Metastasis Reviews.

[7]  A. Williamson,et al.  Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas. , 2007, Virus research.

[8]  I. Ernberg,et al.  Epstein‐Barr virus latent membrane 2A (LMP2A) down‐regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines , 2005, International journal of cancer.

[9]  D. Evanoff,et al.  Recombinant Mycobacterium bovis bacillus Calmette‐Guérin (BCG) expressing mouse IL‐18 augments Th1 immunity and macrophage cytotoxicity , 2004, Clinical and experimental immunology.

[10]  R. Kraus,et al.  ZEB Negatively Regulates the Lytic-Switch BZLF1 Gene Promoter of Epstein-Barr Virus , 2003, Journal of Virology.

[11]  W. Jacobs,et al.  New use of BCG for recombinant vaccines , 1991, Nature.